Google
Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Eileen Hsich, MD
Healthcare Professional Medical Director, Heart Transplant Program
Cleveland Clinic Main Campus
9500 Euclid Avenue
Cleveland, Ohio, United States
Dr. Eileen Hsich is the Medical Director for the Heart Transplant Program and a staff physician in the Section of Heart Failure and Transplantation Medicine of the Robert and Suzanne Tomsich Department of Cardiovascular Medicine, Sydell and Arnold Miller Family Heart and Vascular Institute. She specializes in heart failure in women, heart transplantation, and nuclear cardiology.
Dr. Hsich received her medical degree from The Johns Hopkins University School of Medicine and completed her cardiology fellowship at Tufts-New England Medical Center (NEMC) in Boston. She did cardiovascular basic science research both at the National Institutes of Health (NIH) and Tufts- New England Medical Center where she received the National Research Service Award for Individual Postdoctoral Fellows. She was appointed to The Cleveland Clinic in 2004 after completing her clinical training in heart failure/ heart transplantation at Massachusetts General Hospital in Boston. In 2006, she was appointed Assistant Professor of Medicine at Cleveland Clinic Lerner College of Medicine of Case Western Reserve University.
Dr. Hsich’s research interests center on sex differences in heart failure management and clinical outcome. She has also served as the co-principal investigator on multi-center clinical trials.
Representative Publications:
myBinderRelated Content
-
Catherine Wong, MDDr. Wong worked as Assistant Professor o...
-
Scott C Feitell, DODr. Feitell specializes in Advanced Hear...
-
Martha Grogan, MDMartha Grogan is a Cardiologist-Internis...
-
Leslie T. Cooper, Jr, MDLeslie T. Cooper, Jr., M.D., is a genera...
-
U.S. FDA Approves VYNDAQEL® and VYNDAMAX™ for Use in Patients with Transthyretin Amyloid Cardiomyopathy, a Rare a...Pfizer Inc. announced today that the U.S...
-
US FDA Accepts Regulatory Submissions for Review of Tafamidis to Treat Transthyretin Amyloid CardiomyopathyPfizer Inc. announced today that the US ...
-
Amyloidosis and the Heart: ATTR-Hereditary Amyloidosis Support Meetinghttps://www.dropbox.com/s/z9yjow0iojsqji...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
